|
RPPH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.352300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.908600E-01 |
| Normal-vs-Stage2 |
2.846800E-01 |
| Normal-vs-Stage3 |
9.823700E-02 |
| Normal-vs-Stage4 |
2.105000E-01 |
| Stage1-vs-Stage2 |
8.268000E-01 |
| Stage1-vs-Stage3 |
5.110800E-01 |
| Stage1-vs-Stage4 |
4.710400E-01 |
| Stage2-vs-Stage3 |
6.859400E-01 |
| Stage2-vs-Stage4 |
5.860600E-01 |
| Stage3-vs-Stage4 |
7.869600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.069800E-02 |
| Normal-vs-AfricanAmerican |
3.417600E-01 |
| Normal-vs-Asian |
5.174600E-01 |
| Caucasian-vs-AfricanAmerican |
2.720600E-03 |
| Caucasian-vs-Asian |
7.397700E-03 |
| AfricanAmerican-vs-Asian |
7.742800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.717500E-02 |
| Normal-vs-Female |
2.282600E-01 |
| Male-vs-Female |
7.995400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.697400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.024220E-01 |
| Normal-vs-Age(61-80Yrs) |
1.642570E-01 |
| Normal-vs-Age(81-100Yrs) |
3.738400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.333630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.312400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.761200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.501400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.787800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.362000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.113200E-01 |
| Normal-vs-Grade 2 |
4.806600E-01 |
| Normal-vs-Grade 3 |
3.533800E-02 |
| Normal-vs-Grade 4 |
2.845200E-01 |
| Grade 1-vs-Grade 2 |
1.312150E-01 |
| Grade 1-vs-Grade 3 |
3.182500E-03 |
| Grade 1-vs-Grade 4 |
1.534830E-01 |
| Grade 2-vs-Grade 3 |
2.961200E-01 |
| Grade 2-vs-Grade 4 |
4.754800E-01 |
| Grade 3-vs-Grade 4 |
8.576600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.929800E-02 |
| Normal-vs-ccB subtype |
4.826600E-01 |
| ccA subtype-vs-ccB subtype |
1.483240E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.046300E-02 |
| Normal-vs-N1 |
4.005400E-01 |
| N0-vs-N1 |
5.829800E-01 |
|
|
